The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-05-19
DOI
10.3389/fendo.2014.00076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low circulating IGF-I bioactivity is associated with human longevity: Findings in centenarians’ offspring
- (2016) Giovanni Vitale et al. Aging-US
- Ganitumab (AMG 479) Inhibits IGF-II-Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy
- (2014) P. J. Beltran et al. CLINICAL CANCER RESEARCH
- Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
- (2014) Roberta Malaguarnera et al. ENDOCRINOLOGY
- Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
- (2014) D S Siegel et al. Blood Cancer Journal
- Targeting IGF-1 signaling pathways in gynecologic malignancies
- (2013) Ilan Bruchim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
- (2013) Laura Bergadà et al. Molecular Oncology
- Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
- (2013) Rive Sarfstein et al. PLoS One
- Targeting the Insulin-like Growth Factor Axis for the Development of Novel Therapeutics in Oncology
- (2012) J. Gao et al. CANCER RESEARCH
- The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
- (2012) M. Pollak CLINICAL CANCER RESEARCH
- Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
- (2012) Irène Asmane et al. EUROPEAN JOURNAL OF CANCER
- Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and modulation of the mTOR pathway
- (2012) Rabbie K. Hanna et al. GYNECOLOGIC ONCOLOGY
- BRCA1 is Expressed in Uterine Serous Carcinoma (USC) and Controls Insulin-Like Growth Factor I Receptor (IGF-IR) Gene Expression in USC Cell Lines
- (2012) Keren Amichay et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression
- (2012) Lingling Dong et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Markers for individualised therapy in endometrial carcinoma
- (2012) Helga B Salvesen et al. LANCET ONCOLOGY
- IGF-1 and BRCA1 signalling pathways in familial cancer
- (2012) Haim Werner et al. LANCET ONCOLOGY
- Dual IGF-I/II-Neutralizing Antibody MEDI-573 Potently Inhibits IGF Signaling and Tumor Growth
- (2011) J. Gao et al. CANCER RESEARCH
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Insulin receptor and cancer
- (2011) A. Belfiore et al. ENDOCRINE-RELATED CANCER
- p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy
- (2011) Zohar Attias-Geva et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
- (2011) H Werner ONCOGENE
- The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway
- (2011) Rive Sarfstein et al. PLoS One
- The insulin-like growth factor-I receptor as an oncogene
- (2011) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
- (2010) A Gualberto et al. BRITISH JOURNAL OF CANCER
- The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label study
- (2010) L R Molife et al. BRITISH JOURNAL OF CANCER
- BRCA1/2 Germline Mutations in Jewish Patients With Uterine Serous Carcinoma
- (2010) Ilan Bruchim et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
- (2010) Robert G. Maki JOURNAL OF CLINICAL ONCOLOGY
- Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells
- (2010) Hagit Schayek et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival
- (2008) Ingeborg B. Engelsen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer
- (2008) M. J. Gunter et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- IGF and Insulin Receptor Signaling in Breast Cancer
- (2008) Antonino Belfiore et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons
- (2008) S. John Weroha et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium
- (2007) Giannoula Soufla et al. CANCER LETTERS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started